As on Wednesday, Axogen Inc (NASDAQ: AXGN) got off with the flyer as it spiked 23.06% to $22.25, before settling in for the price of $18.08 at the close. Taking a more long-term approach, AXGN posted a 52-week range of $9.22-$21.00.
In the past 5-years timespan, the Healthcare sector firm’s annual sales growth was 21.24%. Meanwhile, its Annual Earning per share during the time was 21.24%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 121.00%. This publicly-traded company’s shares outstanding now amounts to $45.77 million, simultaneously with a float of $44.85 million. The organization now has a market capitalization sitting at $1.02 billion. At the time of writing, stock’s 50-day Moving Average stood at $16.85, while the 200-day Moving Average is $15.38.
Axogen Inc (AXGN) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Medical Devices industry. Axogen Inc’s current insider ownership accounts for 2.52%, in contrast to 88.84% institutional ownership. Preceding that transaction, on Oct 22 ’25, Company’s Director sold 1,457 for 18.02, making the whole transaction’s value amount to 26,252. This particular insider is now the holder of 100 in total.
Axogen Inc (AXGN) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.05 per share during the current fiscal year.
Axogen Inc’s EPS increase for this current 12-month fiscal period is 121.00% and is forecasted to reach 0.49 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 81.83% through the next 5 years, which can be compared against the 21.24% growth it accomplished over the previous five years trading on the market.
Axogen Inc (NASDAQ: AXGN) Trading Performance Indicators
Let’s observe the current performance indicators for Axogen Inc (AXGN). It’s Quick Ratio in the last reported quarter now stands at 2.67. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 5.04. Similarly, its price to free cash flow for trailing twelve months is now 207.24.
In the same vein, AXGN’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.11, a figure that is expected to reach 0.07 in the next quarter, and analysts are predicting that it will be 0.49 at the market close of one year from today.
Technical Analysis of Axogen Inc (AXGN)
Through scrutinizing the latest numbers posted by the [Axogen Inc, AXGN], it can be observed that its last 5-days Average volume of 1.12 million was better the volume of 0.84 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 84.36% While, its Average True Range was 86.42.
Raw Stochastic average of Axogen Inc (AXGN) in the period of the previous 100 days is set at 94.90%, which indicates a major rise in contrast to 90.89% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.95 that was higher than 0.71 volatility it exhibited in the past 100-days period.
